Indefinite Delivery Contract 72062019D00011

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, has awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract worth up to $107,274,471 to provide preclinical development support for candidate products and drug development activities related to HIV, hepatitis B and C, and tuberculosis. This multiple-award IDIQ contract has a 7-year period of performance from October 2020 to October 2027. The scope...

This indefinite delivery contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide preclinical development support for candidate products addressing HIV, HBV, HCV and other infectious diseases. The multiple award ID/IQ contract holds a potential value of $107 million and a period of performance from October 2020 through October 2027. The contract establishes seven task areas for procuring services such as in vitro testing,...

This is a $190 million single-award Indefinite Delivery Indefinite Quantity (IDIQ) contract awarded by the Department of State's Office of the U.S. Global AIDS Coordinator and Health Diplomacy to Accenture Federal Services LLC, a global professional services firm. The contract provides data and systems support services including engineering, systems, hosting, data collection, analysis, and operational/administrative management. The contract has a 5-year period of performance from July 2024 to...

The National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH) within the Department of Health and Human Services, has awarded a $107,274,471 multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract for Preclinical Services for HIV Therapeutics. The prime contractor, Starks Associates Inc., is a for-profit subchapter S corporation that will provide a range of preclinical development support services, from initial product...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $107,274,471 Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Southern Research Institute, a non-profit research organization, to provide preclinical development support for candidate products and drug development activities related to HIV therapeutics. The contract does not have a set-aside designation and has a period of...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts to provide preclinical development support for candidate products addressing HIV, HBV, HCV, and Mycobacterium tuberculosis. Valued at up to $107 million over seven years, the contracts authorize task orders across seven areas including in vitro testing, synthesis of therapeutic agents, small animal models, formulation development,...

This indefinite delivery contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to support preclinical and translational vaccine development for HIV and other candidate agents. The multiple award IDV has a potential value of $364,553,934 over a seven year ordering period from December 2021 to November 2028. The contract aims to procure a broad range of capabilities for preclinical and translational development support. This includes...

The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded multiple Indefinite Delivery/Indefinite Quantity contracts to support preclinical and translational vaccine development services for HIV vaccines and other candidate agents. The total potential value of the contracts is $364,553,934 over a seven-year period of performance from December 2021 through November 2028. The contracts will provide a broad range of capabilities required for preclinical and...

The National Institute of Allergy and Infectious Diseases, a component of the National Institutes of Health within the Department of Health and Human Services, awarded multiple Indefinite Delivery/Indefinite Quantity contracts valued collectively up to $364.5 million to support preclinical and translational vaccine development services for HIV vaccines and other candidate agents. The ordering period is from December 2021 through November 2028. Under the contracts, the prime contractors will...

The federal contract IDV award is for OTHER PROFESSIONAL SERVICES and was issued by the U.S. Department of Health and Human Services to the prime contractor, Eagle Design & Management, Inc. The single-award, indefinite delivery contract has a total ceiling value of $290,811.00 and a period of performance ending on May 14, 2007. No set-aside was used for this award. The contract aims to procure professional services for the National Center for HIV, STD, and TB Prevention (NCHSTP) program....